Have £2,000 to invest in the FTSE 100? I’d buy these 2 bargain income stocks today

These two FTSE 100 (INDEXFTSE:UKX) dividend shares could deliver high returns in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The uncertain outlook for the UK economy could mean that interest rates remain at a low level for some time. In fact, there are rumours that the next move for interest rates could be downwards, with the Bank of England apparently becoming increasingly dovish as the prospects for the world economy remain challenging.

This could mean that dividend stocks offer increasingly appealing outlooks when compared to other mainstream assets. As such, now could be the right time to buy these two FTSE 100 income shares. They may deliver high income returns, as well as capital growth, over the long run.

GSK

The outlook for GSK (LSE: GSK) and the wider pharmaceuticals industry could improve significantly over the long run. Demand for healthcare-related products and services may rise due to an ageing global population, which could mean that the company’s decision to focus on its pharmaceutical operations leads to an improving rate of profit growth.

However, an improving financial outlook may take time to achieve. In the current year, GSK is forecast to post a fall in earnings of 3%, while growth of 2% in the next financial year may mean that investors struggle to become increasingly bullish about the stock from a growth perspective over the near term.

Of course, its defensive characteristics may boost its appeal in the short run. GSK’s lack of dependence on the wider economy for its growth could lead to increasing demand among investors who could become increasingly risk-averse. Since it offers a dividend yield of around 4.6%, its total returns may therefore be highly attractive.

As such, now could be a good time to buy the stock, with its income prospects, defensive appeal and long-term growth potential suggesting that it may outperform the FTSE 100.

Rio Tinto

Unlike GSK, FTSE 100 index peer Rio Tinto (LSE: RIO) lacks defensive appeal. Its financial performance is closely linked to the prospects for the world economy. Since there are concerns surrounding the outlook for China due in part to the global trade war, it would be unsurprising for the stock’s valuation to come under a degree of pressure in the near term.

However, Rio Tinto’s current valuation suggests that investors may have factored in many of the risks facing the business. It currently trades on a price-to-earnings (P/E) ratio of just 8, which indicates that it has a wide margin of safety. With the company having a relatively low level of gearing, it could prove to be more resilient than some of its sector peers should the performance of the world economy disappoint.

The stock’s dividend yield of 6.9% suggests that it could offer income investing potential over the long run. While there may be more stable income opportunities elsewhere in the FTSE 100, the iron ore miner may be able to produce a high overall return for patient investors.

Peter Stephens owns shares of GlaxoSmithKline and Rio Tinto. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Suddenly investors can’t get enough of GSK shares! What’s going on?

After years in the doldrums, GSK shares are suddenly the most bought stock on the entire FTSE 100. Harvey Jones…

Read more »

'2024' art concept overlaid on a stock screener
Investing Articles

£5,000 invested in Greggs shares in October 2024 is now worth…

Despite facing a multitude of challenges today, might Greggs' stock be worth a look after losing well over a third…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Where will Rolls-Royce shares go next? Let’s ask the experts

Rolls-Royce shares have wobbled as aviation uncertainty grows. But can the City's glowing forecasts help get the price climbing again?

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

No savings at 45? Here’s how investors could still build a £17,360 second income

It’s never too late to start investing, and with compounding working over time, Andrew Mackie shows how investors could still…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

How to invest £10,000 to aim for a £6,108 annual passive income

UK REITs have been getting a lot of attention. But our author thinks they're still the place to look for…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

What sort of passive income stream could you build for a fiver a day?

Think a few pounds a day might not go far? In fact, that could be the basis of some pleasing…

Read more »

British Isles on nautical map
Investing Articles

I sense a potential opportunity if the FTSE 100 loses this quality growth stock…

Rightmove falling out of the FTSE 100 might have been unthinkable a year ago. But that's the reality investors are…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

The largest S&P 500 holding in my ISA is…

Edward Sheldon's making a large bet on this S&P 500 stock. Because he sees the long-term risk/reward proposition very attractive.

Read more »